Based on the Doximity Inc stock forecast from 13 analysts, the average analyst target price for Doximity Inc is USD 42.75 over the next 12 months. Doximity Inc’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Doximity Inc is Slightly Bullish , which is based on 9 positive signals and 6 negative signals. At the last closing, Doximity Inc’s stock price was USD 48.20. Doximity Inc’s stock price has changed by -2.43% over the past week, +14.33% over the past month and +96.57% over the last year.
No recent analyst target price found for Doximity Inc
No recent average analyst rating found for Doximity Inc
Company Overview Doximity Inc
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. It primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California. Read Less
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medic...Read More
Frequently Asked Questions About Doximity Inc (DOCS) Stock
Based on ratings from 13 analysts Doximity Inc's stock is Hold . Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 5 buy, 2 sell and 13 hold ratings.
Unfortunately we do not have enough data on DOCS's stock to indicate if its a good dividend stock.
Based on targets from 13 analysts, the average taret price for DOCS is USD 42.75 over the next 12 months. The maximum analyst target price is USD 75 while the minimum anlayst target price is USD 19.
DOCS stock's Price/Earning ratio is 56.78.
Our analysis grades DOCS stock's Price / Earning ratio at F. This means that DOCS stock's Price/Earning ratio is above 50% of the stocks in the Health Information Services sector in the NYE exchange.
Based on this DOCS may be fairly valued for its sector
The last closing price of DOCS's stock was USD 48.20.
The most recent market capitalization for DOCS is USD 9.22B.
Based on targets from 13 analysts, the average taret price for DOCS is projected at USD 42.75 over the next 12 months.
This means that DOCS's stock price may go down by -11.31% over the next 12 months.
We can't find any ETFs which contains Doximity Inc's stock.
As per our most recent records Doximity Inc has 827 Employees.
Doximity Inc's registered address is 500 3rd Street, San Francisco, CA, United States, 94107.
You can get more information about it from Doximity Inc's website at https://www.doximity.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Doximity Inc (DOCS) Stock
Based on ratings from 13 analysts Doximity Inc's stock is Hold . Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 5 buy, 2 sell and 13 hold ratings.
Unfortunately we do not have enough data on DOCS's stock to indicate if its a good dividend stock.
Based on targets from 13 analysts, the average taret price for DOCS is USD 42.75 over the next 12 months. The maximum analyst target price is USD 75 while the minimum anlayst target price is USD 19.
DOCS stock's Price/Earning ratio is 56.78.
Our analysis grades DOCS stock's Price / Earning ratio at F. This means that DOCS stock's Price/Earning ratio is above 50% of the stocks in the Health Information Services sector in the NYE exchange.
Based on this DOCS may be fairly valued for its sector
The last closing price of DOCS's stock was USD 48.20.
The most recent market capitalization for DOCS is USD 9.22B.
Based on targets from 13 analysts, the average taret price for DOCS is projected at USD 42.75 over the next 12 months.
This means that DOCS's stock price may go down by -11.31% over the next 12 months.
We can't find any ETFs which contains Doximity Inc's stock.
As per our most recent records Doximity Inc has 827 Employees.
Doximity Inc's registered address is 500 3rd Street, San Francisco, CA, United States, 94107.
You can get more information about it from Doximity Inc's website at https://www.doximity.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for DOCS !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
